BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 178.90
-3.40 (-1.87%)
Mar 9, 2026, 4:08 PM HKT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of 261.29 billion as of March 9, 2026. Its market cap has increased by 28.96% in one year.
Market Cap
261.29B
Enterprise Value
234.27B
Revenue
41.59B
Ranking
n/a
PE Ratio
117.00
Stock Price
178.90
Market Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 6.70B to 261.29B, an increase of 3,801.78%. That is a compound annual growth rate of 43.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 261.29B | -0.14% |
| Dec 31, 2025 | 261.67B | 71.29% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 150.36B |
| Innovent Biologics | 144.54B |
| Sino Biopharmaceutical | 109.58B |
| Akeso | 98.84B |
| Sichuan Kelun-Biotech Biopharmaceutical | 90.06B |
| RemeGen | 59.85B |
| 3SBio | 53.95B |
| Shanghai Henlius Biotech | 37.50B |